For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Search Close Search
Page Menu

Developing a Treatment for Previously Non-Healing Wounds in People with Type 2 Diabetes

The Messina Lab has received grant funding from the National Institutes of Health (NIH) to test a novel therapy we’ve developed to treat wounds in older adults living with type 2 diabetes.  We've previously developed and patented a biotherapeutic, that's currently being tested in our unique humanized mouse models.  READ THE FULL STORY

hematopoietic-stem-cell.jpg

Dr. Messina Reunites with Patient for 2nd Surgery

He performed a bypass on Katy when she was 3 years old.  At age 21, she needed it again, and asked him to do it.  The first bypass was only expected to last about 10 years.  Dr. Messina leads the only team in the northeast that can perform this risky surgery.
LEARN MORE